Literature DB >> 10718784

Gastric decontamination performed 5 min after the ingestion of temazepam, verapamil and moclobemide: charcoal is superior to lavage.

O Lapatto-Reiniluoto1, K T Kivistö, P J Neuvonen.   

Abstract

AIMS: The aim was to study the efficacy of gastric lavage and activated charcoal in preventing the absorption of temazepam, verapamil and moclobemide when gastric decontamination was performed immediately after ingestion of the drugs.
METHODS: Nine healthy volunteers took part in a randomized cross-over study with three phases. The subjects were administered single oral doses of 10 mg temazepam, 80 mg verapamil and 150 mg moclobemide. Five minutes later, they were assigned to one of the following treatments: 200 ml water (control), 25 g activated charcoal as a suspension in 200 ml water or gastric lavage. Plasma concentrations and the cumulative excretion into urine of the three drugs were determined up to 24 h.
RESULTS: The mean AUC(0,24 h) of temazepam, verapamil and moclobemide was reduced by 95.2% (P < 0.01), 92.8% (P < 0.01) and 99. 7% (P < 0.01), respectively, by activated charcoal compared with control. Gastric lavage did not reduce significantly the AUC(0,24 h) of these drugs. The 24 h cumulative excretion of temazepam, verapamil and moclobemide into urine was reduced significantly (P < 0.05) by charcoal but not by gastric lavage. Charcoal reduced the AUC(0,24 h), Cmax and urinary excretion of all three drugs significantly more than lavage.
CONCLUSIONS: Activated charcoal is very effective and gastric lavage can be rather ineffective in preventing the absorption of temazepam, verapamil and moclobemide when the treatment is given very rapidly after ingestion of the drugs, before tablet disintegration has occurred.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718784      PMCID: PMC2014923          DOI: 10.1046/j.1365-2125.2000.00138.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatography.

Authors:  R Geschke; J Körner; H Eggers
Journal:  J Chromatogr       Date:  1987-09-04

2.  Liquid-chromatographic quantification compared with gas-chromatographic-mass-spectrometric determination of verapamil and norverapamil in plasma.

Authors:  P A Hynning; P Anderson; U Bondesson; L O Boréus
Journal:  Clin Chem       Date:  1988-12       Impact factor: 8.327

3.  Evaluation of gastric emptying using radionuclides: gastric lavage versus ipecac-induced emesis.

Authors:  W F Young; H G Bivins
Journal:  Ann Emerg Med       Date:  1993-09       Impact factor: 5.721

4.  Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man.

Authors:  P J Neuvonen; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

5.  Determination of diazepam and its pharmacologically active metabolites in blood by bond Elut column extraction and reversed-phase high-performance liquid chromatography.

Authors:  S N Rao; A K Dhar; H Kutt; M Okamoto
Journal:  J Chromatogr       Date:  1982-09-10

6.  A prospective study of acute poisonings in Finnish hospital patients.

Authors:  O Lapatto-Reiniluoto; K T Kivistö; S Pohjola-Sintonen; K Luomanmäki; P J Neuvonen
Journal:  Hum Exp Toxicol       Date:  1998-06       Impact factor: 2.903

7.  Single-dose pharmacokinetics of the MAO-inhibitor moclobemide in man.

Authors:  J Raaflaub; P Haefelfinger; K H Trautmann
Journal:  Arzneimittelforschung       Date:  1984

8.  Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.

Authors:  P J Neuvonen; S M Elfving; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

Review 9.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

10.  Ipecac-induced emesis versus gastric lavage: a controlled study in normal adults.

Authors:  D Tandberg; B G Diven; J W McLeod
Journal:  Am J Emerg Med       Date:  1986-05       Impact factor: 2.469

View more
  4 in total

Review 1.  Management of Calcium Channel Blocker Toxicity in the Pediatric Patient.

Authors:  Jenna W Bartlett; Pamela L Walker
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Sep-Oct

Review 2.  Activated charcoal for acute overdose: a reappraisal.

Authors:  David N Juurlink
Journal:  Br J Clin Pharmacol       Date:  2015-11-09       Impact factor: 4.335

3.  Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults.

Authors:  Maude St-Onge; Kurt Anseeuw; Frank Lee Cantrell; Ian C Gilchrist; Philippe Hantson; Benoit Bailey; Valéry Lavergne; Sophie Gosselin; William Kerns; Martin Laliberté; Eric J Lavonas; David N Juurlink; John Muscedere; Chen-Chang Yang; Tasnim Sinuff; Michael Rieder; Bruno Mégarbane
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

Review 4.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.